Arrowhead Pharmaceuticals, Inc. (ARWR) vs Axsome Therapeutics, Inc. (AXSM)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Axsome Therapeutics, Inc. AXSM 157.14 −2.87%
Arrowhead Pharmaceuticals, Inc. and Axsome Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Axsome Therapeutics, Inc. are of similar size ($8.5B and $8.3B). Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 56.9% against 16.1%. Axsome Therapeutics, Inc. has the higher net margin (−24.7% vs −47.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Axsome Therapeutics, Inc. leads on 9 and Arrowhead Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | ARWR | AXSM | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.24% | 65.16% |
| Operating margin | (33.82%) | (23.96%) | 0.00% |
| Net margin | (47.79%) | (24.68%) | 0.00% |
| Free cash flow margin | (11.22%) | (9.27%) | 0.00% |
| Return on equity | (64.91%) | (245.10%) | (56.36%) |
| Return on assets | (18.32%) | (27.35%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack